dm+d
432254002
Medicine Compliance Aid Stability
ToviazPfizer Ltd
Pfizer Ltd
Toviaz
Tablets m/r f/c 4mg, 8mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Protect from moisture
17 November 2022
Lactation Safety Information
Oxybutynin
Long half-life increases risk of accumulation in breastfed infants
No published evidence of safety
Monitor infant for anticholinergic effects, e.g. urinary retention, colic and constipation
21 September 2020